SmiLe is a leading venture hub that specializes in advancing life science startups from concept to commercialization. Their dynamic ecosystem connects entrepreneurs with seasoned business coaches, industry experts, investors, and sponsors, fostering a collaborative environment that fuels innovation and accelerates business growth.
As part of our commitment to support the growth of small businesses and startups, this sponsorship program is a key initiative to provide SmiLe’s member companies with easy access to our expert services locally in Lund.
Through this partnership, companies within the SmiLe community will gain access to our high-quality expertise throughout the entire process from product development to market approval. GBA Key2Compliance offers guidance and consulting in areas such as quality assurance, regulatory affairs, CE marking, toxicology/biocompatibility, FDA registrations, and evaluation of clinical studies, along with popular training sessions in these subjects.
Starting this summer, SmiLe’s member companies will also have access to test laboratories for medical technology products and a central laboratory tailored for clinical studies through GBA Key2Compliance.
“For us, this partnership is a perfect match with our commitment to help small businesses grow and succeed. We are thrilled to now be part of SmiLe’s community, and we look forward to actively contributing to its continued success. SmiLe’s management is doing a fantastic job. SmiLe has supported over 100 startups so far, and this sponsorship is an expression of our shared goal to promote growth within the life science sector,” says Jan Hellqvist, CEO of GBA Key2Compliance.
“We are excited to welcome GBA Key2Compliance as a new Gold Sponsor for SmiLe and look forward to a close collaboration. Their extensive expertise in medtech, in vitro diagnostics, and pharmaceuticals will be an invaluable asset for our member companies in product development. Additionally, their experience will be a crucial resource for SmiLe’s coaches in supporting companies on the road to commercialization and success,” says Ulrika Ringdahl, COO of SmiLe.
To date, SmiLe’s flagship incubator program has supported over 100 startups, facilitating their collective acquisition of more than EUR 841 million in venture capital and contributing to 21 successful IPOs. Recognized as one of Europe’s leading startup hubs in 2024 by the Financial Times and Statista, SmiLe continues to be a catalyst for innovation in the life sciences sector.
For more information, please contact:
Ulrika Ringdahl, COO of SmiLe, +46 (0) 736 566 232, ulrika.ringdahl@smileincubator.life
Jan Hellqvist, CEO of GBA Key2Compliance +46 (0) 705 612 519, Jan.hellqvist@key2compliance.com
